!!Research output per year
!!Research output per year
Huella digital
Profundizar en los temas de investigación en los que Sajid Khan está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
-
NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress
Xu, Y., Nipper, M. H., Dominguez, A. A., He, C., Sharkey, F. E., Khan, S., Xu, H., Zhou, D., Zheng, L., Luan, Y., Liu, J. & Wang, P., ene 2 2026, En: The Journal of clinical investigation. 136, 1Producción científica: Article › revisión exhaustiva
Acceso abierto1 El enlace se abre en una pestaña nueva Cita (Scopus) -
Discovery of PZ671, a highly potent and in vivo active CRBN-recruiting Bcl-xL degrader
Zhang, P., Thummuri, D., Hu, W., Khan, S., He, Y., Zhang, X., Pal, P., Lv, D., Zhou, D., Zheng, G. & Zhou, D., ago 13 2025, En: RSC Medicinal Chemistry. 16, 8, p. 3495-3506 12 p.Producción científica: Article › revisión exhaustiva
Acceso abierto3 El enlace se abre en una pestaña nueva Citas (Scopus) -
Targeting DDR2 for Treating Pancreatic Cancer
Do, C. T. P., Venkata, P. P., Prochnau, J. Y., Singh, D., Timilsina, S., Subbarayalu, P., Medina, D., Abdulsahib, S., Nirzhor, S., Khan, S., Li, G., Polusani, S. R., Zhou, D., Wang, P., Chen, Y., Vadlamudi, R. K., Hart, M. J., Amaradhi, R., McHardy, S. F. & Rao, M. K., oct 1 2025, En: Molecular cancer therapeutics. 24, 10, p. 1570-1583 14 p.Producción científica: Article › revisión exhaustiva
-
PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
Khan, S., Cao, L., Wiegand, J., Zhang, P., Zajac-Kaye, M., Kaye, F. J., Zheng, G. & Zhou, D., mar 2024, En: Cells. 13, 6, 528.Producción científica: Article › revisión exhaustiva
Acceso abierto27 El enlace se abre en una pestaña nueva Citas (Scopus) -
Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice
Khan, S., Kellish, P., Connis, N., Thummuri, D., Wiegand, J., Zhang, P., Zhang, X., Budamagunta, V., Hua, N., Yang, Y., De, U., Jin, L., Zhang, W., Zheng, G., Hromas, R., Hann, C., Zajac-Kaye, M., Kaye, F. J. & Zhou, D., dic 2023, En: Cell Death Discovery. 9, 1, 1.Producción científica: Article › revisión exhaustiva
Acceso abierto36 El enlace se abre en una pestaña nueva Citas (Scopus)
Conjuntos de datos
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset